MX381845B - Combinación, composición y método de administración de la combinación o composición a animales. - Google Patents

Combinación, composición y método de administración de la combinación o composición a animales.

Info

Publication number
MX381845B
MX381845B MX2016015326A MX2016015326A MX381845B MX 381845 B MX381845 B MX 381845B MX 2016015326 A MX2016015326 A MX 2016015326A MX 2016015326 A MX2016015326 A MX 2016015326A MX 381845 B MX381845 B MX 381845B
Authority
MX
Mexico
Prior art keywords
composition
combination
animals
combinations
administering
Prior art date
Application number
MX2016015326A
Other languages
English (en)
Spanish (es)
Other versions
MX2016015326A (es
Inventor
A Bruce Johnson
David Calabotta
Kenneth W Bafundo
Wendell Knehans
Original Assignee
Phibro Animal Health Corporation
Desert King Int Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phibro Animal Health Corporation, Desert King Int Llc filed Critical Phibro Animal Health Corporation
Publication of MX2016015326A publication Critical patent/MX2016015326A/es
Publication of MX381845B publication Critical patent/MX381845B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2016015326A 2014-05-23 2015-05-22 Combinación, composición y método de administración de la combinación o composición a animales. MX381845B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462002527P 2014-05-23 2014-05-23
PCT/US2015/032301 WO2015179840A1 (en) 2014-05-23 2015-05-22 Combination, composition, and method of administering the combination or composition to animals

Publications (2)

Publication Number Publication Date
MX2016015326A MX2016015326A (es) 2017-05-30
MX381845B true MX381845B (es) 2025-03-13

Family

ID=53366304

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016015326A MX381845B (es) 2014-05-23 2015-05-22 Combinación, composición y método de administración de la combinación o composición a animales.

Country Status (18)

Country Link
US (4) US10413581B2 (https=)
EP (1) EP3145522B1 (https=)
JP (2) JP6869177B2 (https=)
KR (1) KR20170008850A (https=)
CN (1) CN106659787A (https=)
AU (2) AU2015263877B2 (https=)
BR (1) BR112016027335B1 (https=)
CA (1) CA2949965A1 (https=)
CL (1) CL2016002992A1 (https=)
ES (1) ES2856207T3 (https=)
IL (1) IL249061B (https=)
MX (1) MX381845B (https=)
MY (1) MY181854A (https=)
PH (1) PH12016502323A1 (https=)
PL (1) PL3145522T3 (https=)
RU (1) RU2707076C2 (https=)
WO (1) WO2015179840A1 (https=)
ZA (1) ZA201608077B (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6045895B2 (ja) 2012-10-01 2016-12-14 株式会社トプコン 眼科観察装置
US11238056B2 (en) 2013-10-28 2022-02-01 Microsoft Technology Licensing, Llc Enhancing search results with social labels
US11645289B2 (en) 2014-02-04 2023-05-09 Microsoft Technology Licensing, Llc Ranking enterprise graph queries
WO2015123456A1 (en) 2014-02-12 2015-08-20 OmniGen Research, L.L.C. Composition and method for promoting reduction of heat stress in animals
US9870432B2 (en) 2014-02-24 2018-01-16 Microsoft Technology Licensing, Llc Persisted enterprise graph queries
US11657060B2 (en) 2014-02-27 2023-05-23 Microsoft Technology Licensing, Llc Utilizing interactivity signals to generate relationships and promote content
US10757201B2 (en) 2014-03-01 2020-08-25 Microsoft Technology Licensing, Llc Document and content feed
US10394827B2 (en) 2014-03-03 2019-08-27 Microsoft Technology Licensing, Llc Discovering enterprise content based on implicit and explicit signals
US10255563B2 (en) 2014-03-03 2019-04-09 Microsoft Technology Licensing, Llc Aggregating enterprise graph content around user-generated topics
US10169457B2 (en) 2014-03-03 2019-01-01 Microsoft Technology Licensing, Llc Displaying and posting aggregated social activity on a piece of enterprise content
AU2015263877B2 (en) 2014-05-23 2021-01-21 Desert King International Llc Combination, composition, and method of administering the combination or composition to animals
US10061826B2 (en) * 2014-09-05 2018-08-28 Microsoft Technology Licensing, Llc. Distant content discovery
CN120937999A (zh) 2015-09-09 2025-11-14 奥姆尼根研究有限责任公司 颗粒组合物在制备用于施用于水生动物的组合物和/或组合中的用途
US20180325970A1 (en) 2016-07-29 2018-11-15 Saponin Research Center S.A. Use of quillaja saponaria extracts for the prevention and control of bacterial infections in fish
WO2018018171A1 (es) 2016-07-29 2018-02-01 Saponin Research Center S.A. Uso de extractos de quillaja saponaria para la prevención y control de infecciones virales en peces
MX387969B (es) 2017-05-22 2025-03-19 Hoffmann La Roche Composiciones y compuestos terapéuticos, y métodos para su uso.
CN107535727A (zh) * 2017-10-29 2018-01-05 镇江龙润生态农业发展有限公司 一种含有中草药的用于肉鸡无抗生态养殖的饲料添加剂
WO2019147799A1 (en) * 2018-01-24 2019-08-01 Omnigen Research, Llc Bacillus combination for administration to animals
CN108553640A (zh) * 2018-06-13 2018-09-21 佛山市正典生物技术有限公司 一种鸡球虫病弱毒活疫苗及其制备方法和应用
WO2021258056A1 (en) * 2020-06-19 2021-12-23 Kimberly-Clark Worldwide, Inc. Saponin containing extracts prepared from hesperaloe useful in the treatment of non-human animals
US20230302079A1 (en) * 2020-06-19 2023-09-28 Kimberly-Clark Worldwide, Inc. Saponin containing extracts prepared from hesperaloe useful in the treatment of non-human animals
WO2022031753A1 (en) * 2020-08-03 2022-02-10 Robert Scott Foote Supplement for livestock
KR102718991B1 (ko) * 2020-09-25 2024-10-16 씨제이제일제당 (주) 스틸벤계 화합물을 포함하는 항콕시듐증 조성물 및 이의 용도
US20240148671A1 (en) * 2021-03-10 2024-05-09 Cornell University Methods for improving poultry health
CN113057141A (zh) * 2021-05-10 2021-07-02 天津农学院 一种提高蛋鸡蛋黄中卵磷脂含量的饲喂方法
ES2932416B2 (es) * 2021-07-07 2023-09-28 Biovet S A Aditivo para animales que contiene saponinas, compuestos fenolicos y p-cimenol, y procedimiento para su obtencion
WO2023163884A1 (en) * 2022-02-22 2023-08-31 Phibro Animal Health Corporation Liquid formulation comprising yucca and quillaja for administration to animals
WO2024156767A1 (en) * 2023-01-25 2024-08-02 Nutreco Nederland B.V. Method of feeding (pre)ruminants
WO2025085377A1 (en) * 2023-10-16 2025-04-24 Zoetis Services Llc Use of zoalene in livestock

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07107923A (ja) 1993-10-13 1995-04-25 Taiyo Kagaku Co Ltd 飼料用組成物
JP3422834B2 (ja) * 1994-02-09 2003-06-30 日本農産工業株式会社 飼料添加剤
JP3623994B2 (ja) 1994-11-05 2005-02-23 太陽化学株式会社 甲殻類の感染症抑制飼料組成物
JPH09224585A (ja) * 1996-02-26 1997-09-02 F Hoffmann La Roche Ag ニワトリにおける成長促進
TWI223595B (en) 1999-09-07 2004-11-11 Distributors Proc Inc Steroidal sapogenins for the control of coccidiosis in animals
DE19952360A1 (de) 1999-10-30 2001-05-17 Becker Klaus Wolfgang Verwendung von Saponinen und/oder Saponin-Derivaten als Wirkstoff bei der Aufzucht und Mast von Fischen und Krustentieren, deren Einsatz als Futtermittelzusatz sowie Futtermittel, enthaltend diese Futtermittelzusätze
DK1361801T3 (da) 2001-01-08 2007-10-08 Pathway Intermediates Ltd Autoinducerforbindelser og deres anvendelser
JP2004520413A (ja) * 2001-02-27 2004-07-08 セルテクス カンパニー リミテッド 血中コレステロール低下能と心血関係疾患の予防及び治療能を有する組成物
ZA200400479B (en) * 2001-07-06 2006-05-31 Abic Biolog Lab Teva Nucleic acids encoding recombinant 56 a 82 KDA antigens from gametocytes of Eimeria maxima and their use
JP3995541B2 (ja) * 2002-06-28 2007-10-24 株式会社ゲン・コーポレーション 抗鶏コクシジウム症組成物
JP2005532405A (ja) * 2002-07-10 2005-10-27 アクゾ・ノベル・エヌ・ベー 融合タンパク質とサポニンアジュバントとを含む免疫原性組成物
US7416742B2 (en) * 2004-06-16 2008-08-26 Sartec Corporation Methods and compositions for controlling microorganism populations in the digestive system of animals
DK2094278T3 (en) * 2006-11-20 2017-07-24 Duecom USE OF LIPID-CONTAINING PARTICLES INCLUDING QUILLAJA SAPONINS FOR CANCER TREATMENT
TW201010719A (en) * 2008-08-19 2010-03-16 Wyeth Corp Immunological composition
US20100150958A1 (en) * 2008-12-15 2010-06-17 Vectogen Pty Ltd. Methods and Compositions for Use of a Coccidiosis Vaccine
ES2386474B1 (es) * 2011-01-21 2013-07-09 Norel, Sa Aditivos para alimentación animal.
AU2015263877B2 (en) * 2014-05-23 2021-01-21 Desert King International Llc Combination, composition, and method of administering the combination or composition to animals
WO2019147799A1 (en) * 2018-01-24 2019-08-01 Omnigen Research, Llc Bacillus combination for administration to animals

Also Published As

Publication number Publication date
WO2015179840A1 (en) 2015-11-26
JP2017517570A (ja) 2017-06-29
AU2021202307A1 (en) 2021-05-13
AU2015263877B2 (en) 2021-01-21
US20210113647A1 (en) 2021-04-22
MY181854A (en) 2021-01-11
ES2856207T3 (es) 2021-09-27
PH12016502323A1 (en) 2017-02-06
CN106659787A (zh) 2017-05-10
ZA201608077B (en) 2020-01-29
MX2016015326A (es) 2017-05-30
US10912810B2 (en) 2021-02-09
CA2949965A1 (en) 2015-11-26
PL3145522T3 (pl) 2021-06-14
JP2020090502A (ja) 2020-06-11
US20170072002A1 (en) 2017-03-16
AU2021202307B2 (en) 2022-06-30
US12201666B2 (en) 2025-01-21
US10413581B2 (en) 2019-09-17
RU2016149801A (ru) 2018-06-25
AU2015263877A1 (en) 2017-01-12
IL249061A0 (en) 2017-01-31
KR20170008850A (ko) 2017-01-24
RU2707076C2 (ru) 2019-11-22
RU2016149801A3 (https=) 2018-11-14
CL2016002992A1 (es) 2017-05-19
EP3145522A1 (en) 2017-03-29
US20190350998A1 (en) 2019-11-21
JP6869177B2 (ja) 2021-05-12
IL249061B (en) 2020-05-31
EP3145522B1 (en) 2020-12-23
BR112016027335B1 (pt) 2021-06-08
US20250152654A1 (en) 2025-05-15

Similar Documents

Publication Publication Date Title
PH12016502323A1 (en) Combination, composition, and method of administering the combination or composition to animals
MX2015016155A (es) Formulaciones en gel para dirigir la radioterapia.
PH12018500499A1 (en) A composition and/or combination for aquaculture
MX2016011132A (es) Métodos para tratar una infección cutánea mediante la administración de un antagonista de il-4r.
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MY188139A (en) Sodium channel modulators for the treatment of pain
MX365939B (es) Moduladores del transporte nuclear y usos de los mismos.
MX2017000080A (es) Conjugados y particulas direccionados y formulaciones de estos.
PH12017500708A1 (en) Probiotic and prebiotic compositions
MX363007B (es) Uso de n-acetil-5-metoxi-triptamina o analogos de la misma para potenciar el mecanismo de implantacion del embrion, y composiciones y medios de cultivo relacionados.
BR112018009264A2 (pt) composições para cuidados de animais de estimação
PH12019502241A1 (en) Berberine alkaloids in the prevention and/or treatments of intestinal disease
TW201613578A (en) Pharmaceutical combinations
PH12016502352A1 (en) Pharmaceutical composition
NZ754706A (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
TN2016000498A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine.
MX2018014129A (es) Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato.
MX2022014763A (es) Composiciones de grapiprant y metodos para usar las mismas.
MX2016005092A (es) Composiciones farmaceuticas de estradiol insertadas en la vagina y metodos.
MY184630A (en) Tylosin derivatives and method for preparation thereof
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX2019002386A (es) Uso de oligosacaridos de leche humana en el engorde de terneros.
MX2016004961A (es) Procedimientos y composiciones para el tratamiento de infecciones por s. equi.
BR112016029761A8 (pt) composições compreendendo um derivado de ácido quinolona carboxílico e agentes efervescentes, uso das mesmas e forma cristalina do referido derivado
UA108238C2 (xx) Антибактеріальна композиція